Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKAPE.L Regulatory News (KAPE)

  • There is currently no data for KAPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes including appointment of CEO

31 May 2016 07:00

RNS Number : 6432Z
Crossrider plc
31 May 2016
 

Crossrider plc

 

("Crossrider" or the "Group")

 

Board Changes including appointment of CEO

 

Crossrider (AIM:CROS), the creator of digital advertising platforms specialising in monetising web and mobile media through the use of big data, announces the following changes to its Board.

 

Ido Erlichman, has been appointed Group Chief Executive Officer with immediate effect. Ido has more than nine years' experience in the technology sector garnered through roles in private equity, consulting and finance. Prior to joining Crossrider, Ido was acting Joint Chief Executive Officer of VisualDNA*, a leading psychographic data business, where he led its geographic expansion and oversaw significant EBITDA growth.Previously, he also worked as a Senior Associate within KPMG's Private Equity deal advisory practice in London; as a Senior Manager within KPMG's Transaction Services practice focusing on technology deals in Israel; and with the Israeli Ministry of Finance. Ido is Certified Public Accountant, graduated magna cum laude in Accounting and Economics from The Hebrew University of Jerusalem, obtained his Masters degree in Law from Bar-Ilan University, and received an MBA from the University of Cambridge's Judge Business School. VisualDNA is ultimately owned by a trust, the sole beneficiary of which is Teddy Sagi.

 

Following the appointment of a chief executive, Don Elgie's role has reverted to that of Non-Executive Chairman.

 

In addition to the changes above, the Group announces that Mark Carlisle, Chief Financial Officer, has given notice of his intention to resign from his position in order to join another listed company as Chief Financial Officer.

 

Mark will remain with the Group to ensure an orderly handover of his responsibilities and has, therefore, agreed that he will leave his post on 19 August 2016. A search for a new CFO is already underway and a further update will be provided in due course.

 

Commenting on the Board changes, Crossrider's Chairman, Don Elgie, said:

 

"I am delighted to welcome Ido to the Board. Ido brings the required technology credentials and M&A experience from his previous roles, in particular, VisualDNA and KPMG. The Board conducted a thorough strategic search process, including both external and internal candidates and believes Ido has the necessary qualities to take Crossrider to the next phase of its development. I have every confidence in Ido's ability to lead the Group, direct our M&A strategy and lead engagement with our financial stakeholders.

 

"On behalf of the Board, I would like to thank Mark for his contribution since he joined in 2014. He leaves with our best wishes as he embarks on the next stage of his career."

 

*VisualDNA is the trading name of Imagini Europe Limited.

 

 

- Ends -

 

For further information contact:

 

Crossrider plc

Don Elgie, Executive Chairman

Mark Carlisle, Chief Financial Officer

 

+44 (0) 20 3772 2496

via Bell Pottinger

Bell Pottinger

David Rydell

James Newman

Sam Cartwright

 

+44 (0) 20 3772 2496

Shore Capital

Bidhi Bhoma

Toby Gibbs

 

+44 (0) 20 7408 4090

Disclosures pursuant to Schedule 2(g) of the AIM Rules

 

Mr. Erlichman's full name is Ido Erlichman, he is 35 years old.

 

Mr. Erlichman is currently a director of:

RedZone Empire Limited

 

In the past five years he has been a director of:

Imagini Europe Limited, trading as VisualDNA

Duvdevan Association

 

Mr. Erlichman does not hold any other directorships or partnerships.

 

There are no other disclosures required relating to Mr. Erlichman's appointment in accordance with Schedule 2(g) of the AIM Rules.

 

About Crossrider

 

Crossrider is a creator of digital advertising platforms specialising in monetising web and mobile media through the use of big data. The Company's web and mobile platforms power ad networks, agencies and direct publishers and enable the delivery of relevant digital advertising through the analysis of big data: making online marketing significantly more efficient and cost effective.

 

The Group operates web and mobile platforms which generate big data, enabling the development of a proprietary ad serving algorithm and engine that can extract value from this data to deliver relevant advertising to targeted users.

 

Crossrider's vision is to become the de facto standard platform for delivering relevant web and mobile adverts to billions of people, powering the next generation of digital advertising.

 

www.crossrider.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADDGDUUDXBGLG
Date   Source Headline
22nd Mar 20227:00 amRNSFinal Results
18th Mar 20224:34 pmRNSBlock listing Interim Review
15th Mar 20227:00 amRNSAnalyst and Investor Presentations
19th Jan 202212:30 pmRNSHolding(s) in Company
19th Jan 202210:00 amRNSDirector/PDMR Shareholding
18th Jan 20227:01 amRNSDirectorate Changes
18th Jan 20227:00 amRNSTrading Update, Presentation & Notice of Results
5th Jan 20227:00 amRNSIssue of Equity
20th Dec 20211:00 pmRNSHolding(s) in Company
20th Dec 20217:00 amRNSHolding(s) in Company
20th Dec 20217:00 amRNSHolding(s) in Company
15th Dec 20213:21 pmRNSCompletion of acquisition & business update
12th Nov 20213:10 pmRNSHolding(s) in Company
25th Oct 20217:00 amRNSHolding(s) in Company
4th Oct 20217:00 amRNSDirector/PDMR Dealings & Exercise of Options
1st Oct 20211:01 pmRNSResults of General Meeting and Total Voting Rights
27th Sep 20217:00 amRNSHolding(s) in Company
21st Sep 20217:00 amRNSHalf-year Results
16th Sep 202112:12 pmRNSSecond Price Monitoring Extn
16th Sep 202112:11 pmRNSPrice Monitoring Extension
16th Sep 20217:00 amRNSNotice of Results & Analyst/Investor Presentation
15th Sep 20212:00 pmRNSPosting of Shareholder circular and notice of GM
14th Sep 20219:05 amRNSSecond Price Monitoring Extn
14th Sep 20219:00 amRNSPrice Monitoring Extension
14th Sep 20217:00 amRNSResult of Placing & Retail Offer & Notice of GM
13th Sep 20214:41 pmRNSRetail Offer by PrimaryBid
13th Sep 20214:40 pmRNS$936m acquisition of ExpressVPN & $354m Placing
13th Sep 20217:00 amRNSBlocklisting Return & Total Voting Rights
20th Jul 20217:00 amRNSTrading Update
15th Jul 20217:00 amRNSPIA introduces a new way of VPN subscription
28th May 20217:00 amRNSNew Bank Facility
20th May 20212:18 pmRNSResults of AGM
20th May 20217:00 amRNSAGM Statement
6th May 202111:36 amRNSTotal Voting Rights
29th Apr 20217:00 amRNSExercise of Options and Director/PDMR Shareholding
26th Apr 20217:00 amRNSPosting of Annual Report and Notice of AGM
31st Mar 20217:00 amRNSPDMR Dealings
26th Mar 20211:49 pmRNSResult of General Meeting and Total Voting Rights
19th Mar 20217:00 amRNSInvestor Presentation
17th Mar 202112:13 pmRNSBlocklisting Return
17th Mar 20217:00 amRNSFinal Results
10th Mar 20217:00 amRNSNotice of General Meeting
8th Mar 202111:05 amRNSSecond Price Monitoring Extn
8th Mar 202111:00 amRNSPrice Monitoring Extension
8th Mar 20217:00 amRNSAcquisition of Webselenese
19th Jan 20217:00 amRNSTrading Update & Notice of Results
11th Jan 20217:00 amRNSAppointment of Joint Broker
6th Jan 20217:00 amRNSAppointment of Non-executive Director
5th Jan 202111:54 amRNSTotal Voting Rights
30th Dec 20202:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.